As of Friday’s close, gold is up 20% year to date (YTD), and is trading at its highest level in more than six years.
Chemesis International (CSI.C) expanded its global footprint on Monday by announcing a new U.K. purchase order for its CBD products.
The U.S. Drug Enforcement Agency (D.E.A.) says it will be “moving forward to facilitate and expand scientific and medical research for marijuana,” allowing for additional federally-permitted cannabis cultivators.
Johnson & Johnson (JNJ.NYSE) is to pay $572 million as finger-pointing gets under way in opioid epidemic
An Oklahoma district court judge has ordered Johnson & Johnson (JNJ.NYSE) to pay $572 million for its part in the state’s opioid epidemic.
Earlier this month, Mexican President Andrés Manuel López Obrador promised radical changes in the country’s approach to drugs if he was elected—namely, he was going to decriminalize them. He added the addendum that drugs wouldn’t be illegal, and arrests would be replaced by enforced treatment, like being forced into a detox program.
Earlier this month, a news blurb all of 184 words published by thecannabisstock.com ran with the headline, “HEXO is officially not responsible for the death of thousands of fish in Gatineau,” raising more questions than answers.
NVIDIA (NVDA.Q) and VMware (VMW.NYSE) are joining forces to deliver enhanced GPU services for the latter’s VMware Cloud on AWS integrated cloud service.